Bayer has announced that they will settle approximately 75% of the approximately 125,000 lawsuits from plaintiffs who claim to have developed non-Hodgkin’s Lymphoma due to Roundup exposure. The German pharmaceutical giant has been plagued with litigation regarding the world’s most used herbicide since it purchased Monsanto in 2018. Bayer issued a press release on Wednesday with the details of this move.
Related: Foods Most Likely to Contain Glyphosate
The company will make a payment of $8.8 billion to $9.6 billion to resolve the current Roundup™ litigation, including an allowance expected to cover unresolved claims, and $1.25 billion to support a separate class agreement to address potential future litigation.”
Bayer
Only three cases against Roundup have gone to trial. Each trial ended in a substantial decision for the plaintiffs, with monetary awards of $289 million, $80 million, and $2 billion. The newly announced settlements are subject to approval by Judge Vince Chhabria, who has previously upheld jury verdicts against the company and was also responsible for reducing $80 million in damages to $25 million. These previous jury verdicts are not part of the settlement agreement, and Bayer has indicated they will continue to appeal those cases.
Related: How to Eliminate IBS, IBD, Leaky Gut
Latest posts by Kristina Martin (see all)
- Renewable Energy Reduces Carbon Emissions More Than Nuclear Energy, Says New Study - October 23, 2020
- Chewing Gum is Full of Plastic and Wax - October 14, 2020
- Cannabis Use Increases Need for Painkillers After Surgery, Says Study - October 14, 2020